QuickLinks -- Click here to rapidly navigate through this document

~~ASSETS~~SECURITIES ~~JUNE~~AND ~~30,~~EXCHANGE 2000 (UNAUDITED) ---------------------------------------------- HISTORICAL ADJUSTMENT PRO FORMA ---------- ---------- --------- Current assets: Cash............................................................. $ 22COMMISSION Washington,~~483~~ ~~$ 30,000 (A) $ 22,310 (18,273) (B) (11,900) (C) Receivables, net................................................. 78,419 (1,551) (~~D~~) 76,868 Inventories~~.C.~~....................................................~~ 74,247 (2,127) (E) 72,120 Prepaid expenses and other current assets........................ 24,727 24,727 ----------- ----------- ----------- Total current assets......................................... 199,876 (3,851) 196,025 ----------- ----------- ----------- Net investment in sales-type leases, less current portion............ 24,412 - 24,412 Property, plant and equipment, net................................... 65,106 (907) (F) 64,199 Other non-current assets............................................. 25,924 25,924 Intangible assets, net............................................... 267,289 (13,429) (G) 253,860 ----------- ----------- ----------- $ 582,607 $ (18,187) $ 564,420 =========== =========== =========== LIABILITIES AND STOCKHOLDER'S EQUITY Current liabilities: Current portion of long-term debt................................ $ 18,147 $ (1,762) (B) $ 16,385 Accounts payable................................................. 20,301 20,301 Accrued expenses and other current liabilities................... 39,100 (100) (H) 39,000 ----------- ----------- ----------- Total current liabilities..................................... 77,548 (1,862) 75,686 ----------- ----------- ----------- Long-term debt....................................................... 371,503 (16,478) (B) 355,025 Other non-current liabilities........................................ 35,446 (5,451) (I) 29,995 ----------- ----------- ----------- Total non-current liabilities................................. 406,949 (21,929) 385,020 ----------- ----------- ----------- Contingent liabilities and commitments Stockholder's equity: Common stock and capital in excess of par value, authorized 3,000 common shares at $.01 par value; 1,000 issued and outstanding at June 30, 2000................. 203,684 203,684 Accumulated deficit.............................................. (99,248) 5,604 (J) (93,644) Accumulated other comprehensive loss............................. (6,326) (6,326) ----------- ----------- ----------- Total stockholder's equity.................................... 98,110 5,604 103,714 ----------- ----------- ----------- $ 582,607 $ (18,187) $ 564,420 =========== =========== ===========20549

~~SIX~~FORM ~~MONTHS ENDED JUNE 30, 2000 (UNAUDITED)~~ 8------------------------------------------- HISTORICAL ADJUSTMENT(A) PRO FORMA ---------- ------------- --------- Sales........................................................................ $ 189,019 $ 6,618 $ 182,401 Cost of sales................................................................ 102,183 4,149 98,034 ----------- ---------- ---------- Gross margin............................................................. 86,836 2,469 84,367 ----------- ---------- ---------- Selling and marketing expenses............................................... 37,717 2,115 35,602 General and administrative expenses.......................................... 19,919 626 19,293 Research and development expenses............................................ 12,008 1,021 10,987 Restructuring charges........................................................ 535 - 535 ----------- ---------- ---------- Total operating expenses................................................. 70,179 3,762 66,417 ----------- ---------- ---------- Lease interest income........................................................ 2,453 - 2,453 ----------- ---------- ---------- Income (loss) from operations............................................ 19,110 (1,293) 20,403 Other income (expenses): Interest income............................................................ 489 - 489 Interest expense........................................................... (20,646) (891) (B) (19,755) Other, net................................................................. 1,142 - 1,142 ----------- ---------- ---------- Total other expense...................................................... (19,015) (891) (18,124) ----------- ---------- ---------- Income (loss) before income taxes............................................ 95 (2,184) 2,279 Provision for (benefit from) income taxes.................................... 60 (1,240) (C) 1,300 ----------- ---------- ---------- Net income (loss) ........................................................... $ 35 $ (944) $ 979 =========== ========== ==========K

~~SIX~~CURRENT MONTHS ENDED JUNE 30, 1999 (UNAUDITED) ------------------------------------------- HISTORICAL ADJUSTMENT(A) PRO FORMA ---------- ------------- --------- Sales........................................................................ $ 193,051 $ 7,773 $ 185,278 Cost of sales................................................................ 100,597 4,675 95,922 ----------- ---------- ---------- Gross margin............................................................. 92,454 3,098 89,356 ----------- ---------- ---------- Selling and marketing expenses............................................... 39,085 2,350 36,735 General and administrative expenses.......................................... 22,027 1,996 20,031 Research and development expenses............................................ 12,598 971 11,627 Restructuring, integration and other non-recurring charges................... 3,438 3,389 49 ----------- ---------- ---------- Total operating expenses................................................. 77,148 8,706 68,442 ----------- ---------- ---------- Lease interest income........................................................ 2,080 - 2,080 ----------- ---------- ---------- Income (loss) from operations............................................ 17,386 (5,608) 22,994 Other income (expenses): Interest income............................................................ 761 - 761 Interest expense........................................................... (19,910) (713) (B) (19,197) Other, net................................................................. (873) 17 (890) ----------- ---------- ---------- Total other expense...................................................... (20,022) (696) (19,326) ----------- ---------- ---------- (Loss) income before income taxes............................................ (2,636) (6,304) 3,668 (Benefit from) provision for income taxes.................................... (1,500) (3,600) (C) 2,100 ----------- ---------- ---------- Net (loss) income............................................................ $ (1,136) $ (2,704) $ 1,568 =========== ========== ==========REPORT

~~YEAR~~ ~~ENDED~~PURSUANT ~~DECEMBER~~TO ~~31,~~SECTION 13 ~~1999~~OR --------------------------------------- HISTORICAL ADJUSTMENT(A) PRO FORMA ---------- ------------- --------- (UNAUDITED) (UNAUDITED) Sales........................................................................ $ 401,978 $ 14,386 $ 387,592 Cost of sales................................................................ 208,739 8,817 199,922 ----------- ---------- ---------- Gross margin............................................................. 193,239 5,569 187,670 ----------- ---------- ---------- Selling and marketing expenses............................................... 77,510 4,097 73,413 General and administrative expenses.......................................... 44,639 3,934 40,705 Research and development expenses............................................ 23,769 1,635 22,134 Restructuring, integration and other non-recurring charges................... 26,589 23,701 2,888 ----------- ---------- ---------- Total operating expenses................................................. 172,507 33,367 139,140 ----------- ---------- ---------- Lease interest income........................................................ 4,425 - 4,425 ----------- ---------- ---------- Income (loss) from operations............................................ 25,157 (27,798) 52,955 Other income (expenses): Interest income............................................................ 1,373 - 1,373 Interest expense........................................................... (39,949) (1,476) (B) (38,473) Other, net................................................................. (1,649) 16 (1,665) ----------- ---------- ----------- Total other expense...................................................... (40,225) (1,460) (38,765) ----------- ----------- ---------- (Loss) income before income taxes............................................ (15~~,068)~~ (~~29,258~~d) ~~14,190~~OF THE ~~Provision~~SECURITIES ~~for~~EXCHANGE ~~(benefit~~ACT ~~from)~~OF income taxes.................................... 3,400 (5,500) (C) 8,900 ----------- ----------- ---------- Net (loss) income ........................................................... $ (18,468) $ (23,758) $ 5,290 ========== ========== ==========1934

~~YEAR~~ ~~ENDED DECEMBER 31~~September 12, ~~1998~~2001 ~~--------------------------------------- HISTORICAL ADJUSTMENT~~(A)September 7, ~~PRO FORMA ---------- ------------- --------- (UNAUDITED~~2001) (~~UNAUDITED)~~Date ~~Sales........................................................................ $ 380,068 $ 8,430 $ 371,638 Cost~~ of sales................................................................ 191,232 5,155 186,077 ----------- ---------- ---------- Gross margin............................................................. 188,836 3,275 185,561 ----------- ---------- ---------- Selling and marketing expenses............................................... 72,202 2,213 69,989 General and administrative expenses.......................................... 40,952 1,830 39,122 Research and development expenses............................................ 20,059 824 19,235 Purchased in-process research and development................................ 28,334 22,800 5,534 Integration charges.......................................................... 1,901 1,763 138 ----------- ---------- ---------- Total operating expenses................................................. 163,448 29,430 134,018 ----------- ---------- ---------- Lease interest income........................................................ 4,599 - 4,599 ----------- ---------- ---------- Income (lossReport) ~~from operations............................................ 29,987~~ (~~26,155)~~Date ~~56,142~~of ~~Other~~earliest ~~income~~event ~~(expenses~~reported): Interest income............................................................ 1,128 8 1,120 Interest expense........................................................... (41,814) (704) (B) (41,110) Other, net................................................................. (1,100) 16 (1,116) ----------- ---------- ---------- Total other expense...................................................... (41,786) (680) (41,106) ----------- ---------- ---------- (Loss) income before income taxes............................................ (11,799) (26,835) 15,036 Provision for (benefit from) income taxes.................................... 7,400 (1,000) (C) 8,400 ----------- ---------- ---------- Net (loss) income ........................................................... $ (19,199) $ (25,835) $ 6,636 =========== ========== ==========

ALARIS MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in charter)

Delaware
(State or other jurisdiction of incorporation)

333-18687
(Commission File Number)

13-3800335
(IRS Employer Identification No.)

10221 Wateridge Circle
San Diego, CA 92121
(Address of principal executive officers)

(858) 458-7000
(Registrant's telephone number, including area code)

Exhibit Index is on Page

ITEM 5. OTHER EVENTS

On September 7, 2001, ALARIS Medical, Inc. issued a press release stating that its operating company, ALARIS Medical Systems, Inc. (the "Registrant" or "Systems"), is planning to offer approximately $150 million of senior secured notes due in 2006 in a private offering and concurrently with the closing of such offering, to enter into a $20 million revolving credit facility with one or more banks. The financing, which the company anticipates closing in October 2001, would replace Systems' existing bank credit facility.

The press release is attached as Exhibit 1 to this Form 8-K filing.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

(c): Exhibit 1—Press Release dated September 7, 2001

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ALARIS MEDICAL SYSTEMS, INC. (Registrant)

Date: September 12, 2001	By:	/s/ WILLIAM C. BOPP
	Name:	William C. Bopp
	Title:	Senior Vice President and Chief Financial Officer

EXHIBIT INDEX

Exhibit Number		Material to be Filed as Exhibits		Page Number
Exhibit 99.1		Press Release dated September 7, 2001

QuickLinks

SIGNATURES
EXHIBIT INDEX

Filing Compare · ALARIS MEDICAL SYSTEMS INC